BioAge Labs Inc (NASDAQ: BIOA) started the day on Thursday, with a price increase of 3.20% at $3.87, before settling in for the price of $3.75 at the close. Taking a more long-term approach, BIOA posted a 52-week range of $2.88-$26.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 0.00% over the last 5 years. Nevertheless, stock’s Earnings Per Share (EPS) this year is 67.82%. This publicly-traded company’s shares outstanding now amounts to $35.85 million, simultaneously with a float of $21.04 million. The organization now has a market capitalization sitting at $138.74 million. At the time of writing, stock’s 50-day Moving Average stood at $4.12.
BioAge Labs Inc (BIOA) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – Specialty & Generic Industry. BioAge Labs Inc’s current insider ownership accounts for 41.30%, in contrast to 30.55% institutional ownership. According to the most recent insider trade that took place on Sep 27 ’24, this organization’s Principal Accounting Officer bought 2,632 shares at the rate of 18.00, making the entire transaction reach 47,376 in total value, affecting insider ownership by 2,632. Preceding that transaction, on Oct 01 ’24, Company’s Director bought 126,793 for 19.73, making the whole transaction’s value amount to 2,501,626. This particular insider is now the holder of 1,026,793 in total.
BioAge Labs Inc (BIOA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.
BioAge Labs Inc’s EPS increase for this current 12-month fiscal period is 67.82% and is forecasted to reach -2.37 in the upcoming year.
BioAge Labs Inc (NASDAQ: BIOA) Trading Performance Indicators
Let’s observe the current performance indicators for BioAge Labs Inc (BIOA). It’s Quick Ratio in the last reported quarter now stands at 12.86. The Stock has managed to achieve an average true range (ATR) of 0.27.
In the same vein, BIOA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.05, a figure that is expected to reach -0.53 in the next quarter, and analysts are predicting that it will be -2.37 at the market close of one year from today.
Technical Analysis of BioAge Labs Inc (BIOA)
If we take a close look at the recent performances of BioAge Labs Inc (NASDAQ: BIOA), its last 5-days Average volume was 0.24 million that shows plunge from its year to date volume of 0.27 million. During the previous 9 days, stock’s Stochastic %D was recorded 91.90% While, its Average True Range was 0.26.
Raw Stochastic average of BioAge Labs Inc (BIOA) in the period of the previous 100 days is set at 5.66%, which indicates a major fall in contrast to 92.52% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 65.11% that was lower than 242.47% volatility it exhibited in the past 100-days period.
